News & Events
Contacts:
Investor Relations
703.742.5393
QuadraMed to Announce Q3 2009 Results on November 5, 2009
Reston, VA October 29, 2009
RESTON, Va.--(BUSINESS WIRE)--Oct. 29, 2009--
QuadraMed® Corporation (NASDAQ:QDHC) announced today that it
expects to release its third quarter 2009 financial results on Thursday,
November 5, 2009. Management will review these results in an investment
community conference call on Thursday, November 5, 2009 at 5:00 PM
Eastern (2:00 PM Pacific). To ensure fair dissemination of information,
management will not answer any questions regarding QuadraMed’s results
until after the conference call on November 5th. A brief
question and answer period will follow management’s presentation.
The dial-in number for the conference call is 800-974-2159 domestic and
973-638-3397 international. Callers should dial in by 4:45 PM Eastern
(1:45 PM Pacific) to register. The call will also be webcast live and
available to the public via the Investor Relations section of
QuadraMed’s webpage at www.quadramed.com.
Please note that the webcast is listen-only. Listeners should access the
website at 4:45 PM Eastern (1:45 PM Pacific) to register and to download
and install any necessary audio software. Webcast replays will be
available two hours after the live call is completed.
About QuadraMed Corporation
QuadraMed Corporation advances the success of healthcare organizations
through IT solutions that leverage quality care into positive financial
outcomes. QuadraMed provides real world solutions that help healthcare
professionals deliver outstanding patient care efficiently and cost
effectively. Behind the Company’s products and services is a staff of
600 professionals whose experience and dedication have earned QuadraMed
the trust and loyalty of clients at over 2,000 healthcare provider
facilities. For more information about QuadraMed, visit http://www.quadramed.com.
Cautionary Statement on Risks Associated with QuadraMed
Forward-Looking Statements
This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995 that are
subject to risks and uncertainties. The words “believe,” “expect,”
“target,” “goal,” “project,” “anticipate,” “predict,” “intend,” “plan,”
“estimate,” “may,” “will,” “should,” “could” and similar expressions and
their negatives are intended to identify such statements.
Forward-looking statements are not guarantees of future performance,
anticipated trends or growth in businesses, or other characterizations
of future events or circumstances and are to be interpreted only as of
the date on which they are made. QuadraMed undertakes no obligation to
update or revise any forward-looking statement. You should not place
undue reliance on these forward-looking statements. Our actual results
could differ materially from those anticipated in these forward-looking
statements for many reasons, including the risks faced by QuadraMed
described in documents filed with the Securities and Exchange Commission
("SEC") from time to time. QuadraMed’s SEC filings can be accessed
through the Investor Relations section of our website, www.quadramed.com,
or through the SEC’s EDGAR Database at www.sec.gov
(QuadraMed has EDGAR CIK No. 0001018833).
QuadraMed is a registered trademark of QuadraMed Corporation. All other
trademarks are the property of their respective holders.
Source: QuadraMed Corporation
###